NFCR Funds Critical TGen-UA Cancer Research: Pancreatic Cancer Targeted By Specific Therapies With Fewer Side Effects
PHOENIX, Ariz. - Jan. 31, 2012 - The Translational Genomics Research Institute (TGen) and the University of Arizona (UA) have received a three-year, $600,000 grant to study targeted cancer therapies from NFCR.










